（May 30, 2014）Earlier this month, Wincon attended 2014 ARVO conference in Orlando for ophthalmological diseases and therapies. The natural occurring ophthalmological non-human primate (NHP) models and technical capabilities Wincon showcased at ARVO receive great responses from both pharmaceutical industry and academic institutions. Wincon has been devoted in providing reliable and clinical-like NHP models for testing of novel ideas, drugs and/or instruments. The natural occurring ophthalmological disease models include: drusens, diabetic retinopathy, macular degeneration,cataract and other vision impairing diseases. These models are established upon professional techniques and vast NHP resource possessed throughout over ten years operation.

Nov. 13, 2013-Scientists of Wincon and University of Kentucky presented their recent findings in the annul meeting of the Society for Neuroscience Nov. 9-13 2013 in San Diego, California. In the nonhuman primate study, they found that cognitive deficits associated with aging differ from those seen in parkinonsonian cynomolgus monkeys on the same cognitive tasks. Program #770.16

April 22, 2014- Wincon will attend and exhibit at the ARVO/ISIE Imaging Conference 2014 in Orlando, USA from May 4 to May 8, 2014. You are cordially invited to visit us at booth #214. For more information about our participation, please contact us at This email address is being protected from spambots. You need JavaScript enabled to view it.. Background of the meeting The ARVO/ISIE Imaging conference is a forum for the presentation of current clinical and basic science advances in glaucoma, retina, cornea, anterior segment, orbit and neuro-imaging in ophthalmology. Didactic paper presentations will be followed by poster presentations.